Results 251 to 260 of about 211,400 (307)

Real‐World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity‐Matched Study from the EUSTAR Cohort

Arthritis Care &Research, Accepted Article.
Objective JAK inhibitors (JAKis) have shown promising effects in early‐phase studies of SSc. We aimed to assess the safety and explore effectiveness of JAKis compared to conventional immunosuppressants in SSc. Methods A longitudinal retrospective study of the EUSTAR cohort was performed.
Stefano Di Donato, Marie‐Elise Truchetet, Marco Minerba, Oliver Distler, Juan José Alegre Sancho, Yolanda Braun‐Moscovici, Christina Bergmann, Petros Sfikakis, Jeska K de Vries‐Bouwstra, Murray Baron, Silvia Bellando‐Randone, Lorenzo Dagna, Christopher P Denton, Madelon C Vonk, Vanessa Smith, Ivan Castellvi, Gabriela Riemekasten, Andra Balanescu, Masataka Kuwana, Maria De Santis, Kamal Solanki, Anastas Batalov, Vahan Mukuchyan, Marco Matucci‐Cerinic, Yannick Allanore, Francesco Del Galdo, Michael Hughes, EUSTAR Collaborators   +27 more
wiley   +1 more source

Exploring the Potential of Nanogels: From Drug Carriers to Radiopharmaceutical Agents. [PDF]

Adv Healthc Mater
Kubeil M, Suzuki Y, Casulli MA, Kamal R, Hashimoto T, Bachmann M, Hayashita T, Stephan H.   +7 more
europepmc   +1 more source

Investigating the Effectiveness of Different Porous Nanoparticles as Drug Carriers for Retaining the Photostability of Pinosylvin Derivative. [PDF]

Pharmaceutics
Howaili F, Saadabadi A, Mäkilä E, Korotkova E, Eklund PC, Salo-Ahen OMH, Rosenholm JM.   +6 more
europepmc   +1 more source

The erythrocyte as a carrier of drugs.

Japanese Journal of National Medical Services, 1988
openaire   +1 more source

Inflammation Unchecked: Concurrent Kawasaki Disease and Stevens‐Johnson Syndrome in an 18‐Month‐Old Child

Arthritis Care &Research, EarlyView.
Catherine Deffendall, Jodi Backalar, Elizabeth Acevedo Zapata, Adriana Della Porta, Lorin Bibb, Tyler Reese, Charlotte M. Brown   +6 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Liposomes as drug carriers

Life Sciences, 1977
Abstract The use of liposomes as drug carrying vehicles are summarized. Introduction of smaller doses, increased permeability, reduced toxicological and allergic effects and altered immunological responses are the advantages of the method. Experimental techniques for the preparation of drug containing liposomes and for their deliveries are surveyed ...
J H, Fendler, A, Romero
openaire   +2 more sources

Drug carriers for vascular drug delivery

IUBMB Life, 2011
AbstractThe currently used drug carriers for vascular drug delivery are reviewed. The human vascular system possesses unique physiological features that can be exploited for enhanced and effective targeted drug delivery. Although the thin layer of endothelial cells (EC) lines the interior surface of blood vessels forming an interface between ...
Erez, Koren, Vladimir P, Torchilin
openaire   +2 more sources

In vivo Fate of Targeted Drug Delivery Carriers

International Journal of Nanomedicine
Fan Zhao,1,2 Jitong Wang,1,2 Yu Zhang,1,2 Jinru Hu,1,2 Chenyang Li,3 Shuainan Liu,4,5 Ruixiang Li,2 Ruofei Du1,2 1Engineering Research Center of Modern Preparation Technology of TCM, Ministry of Education, Shanghai, 201203, People’s Republic of China ...
Fan Zhao, Shuainan Liu, Ruixiang Li
exaly   +2 more sources

Microemulsions as carriers for drugs and nutraceuticals

Advances in Colloid and Interface Science, 2006
Microemulsions are potentially excellent carriers for bioactive molecules. They offer the advantage of spontaneous formation, ease of manufacture, thermodynamic stability, and improved solubilization of bioactive materials. This review explores some of the new trends in microemulsion research through analysis of some representative studies.
Aviram, Spernath, Abraham, Aserin
openaire   +2 more sources

Liposomes as Carriers of Antimicrobial Drugs

Drug Development and Industrial Pharmacy, 1997
Liposome are promising drug carrier systems being developed. Their successful use in the treatment of several diseases demonstrates that a solid rationale for clinical development of liposomes as antimicrobial drug carriers can be established. There are a number of potential drug candidates for liposome encapsulation.
Šiler-Marinković, Slavica, Mojović, Ljiljana, Davinić, V, Bugarski, Branko   +3 more
openaire   +2 more sources